RICHARD KELLERMAYER to Treatment Outcome
This is a "connection" page, showing publications RICHARD KELLERMAYER has written about Treatment Outcome.
Connection Strength
0.414
-
Fecal Microbiota Transplantation Commonly Failed in Children With Co-Morbidities. J Pediatr Gastroenterol Nutr. 2022 02 01; 74(2):227-235.
Score: 0.065
-
Updates and Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. J Pediatr Gastroenterol Nutr. 2021 10 01; 73(4):430-432.
Score: 0.064
-
Alternative Diagnoses in Pediatric Fecal Microbiota Transplant Referral Patients. J Pediatr Gastroenterol Nutr. 2021 05 01; 72(5):693-696.
Score: 0.062
-
Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model. Gut Microbes. 2019; 10(4):504-520.
Score: 0.053
-
Duration of disease may predict response to infliximab in pediatric ulcerative colitis. J Clin Gastroenterol. 2014 Mar; 48(3):248-52.
Score: 0.038
-
Steroid responsive eosinophilic gastric outlet obstruction in a child. World J Gastroenterol. 2008 Apr 14; 14(14):2270-1.
Score: 0.025
-
Clinical challenges and images in GI. Aortitis as a rare complication of Crohn's disease. Gastroenterology. 2008 Mar; 134(3):668, 898.
Score: 0.025
-
Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients. J Pediatr Gastroenterol Nutr. 2023 04 01; 76(4):440-446.
Score: 0.017
-
Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease. J Crohns Colitis. 2022 06 24; 16(5):768-777.
Score: 0.017
-
Pediatric Fecal Microbiota Transplantation in Recurrent Clostridioides Difficile. Pediatr Ann. 2021 Dec; 50(12):e515-e521.
Score: 0.016
-
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children. Clin Gastroenterol Hepatol. 2020 03; 18(3):612-619.e1.
Score: 0.013
-
Evaluating the impact of infliximab use on surgical outcomes in pediatric Crohn's disease. J Pediatr Surg. 2016 May; 51(5):786-9.
Score: 0.011
-
Increased effectiveness of early therapy with anti-tumor necrosis factor-a vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014 Feb; 146(2):383-91.
Score: 0.009